Inductive Bio Just Got a $21M Mission: Rewrite AI Drug Safety From Scratch
Inductive Bio just picked up up to $21 million to tackle one of pharma’s biggest blind spots: predicting whether a drug will actually be safe for humans before it enters the clinic. The award comes from ARPA-H, the US health innovation agency pushing moonshot-style projects. … Read more